KNOTT DAVID M - Q4 2020 holdings

$221 Million is the total value of KNOTT DAVID M's 145 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 32.7% .

 Value Shares↓ Weighting
LGND  Ligand Pharmaceuticals Incorporated$24,667,000
+4.3%
248,0410.0%11.16%
-19.5%
UPLD  Upland Software, Inc.$18,654,000
+21.7%
406,5000.0%8.44%
-6.1%
FTAI  Fortress Trans & Infrastructure Inv. LLC$16,422,000
+37.0%
700,0000.0%7.43%
+5.6%
APO  Apollo Global Management, Inc.$14,694,000
+9.5%
300,0000.0%6.65%
-15.6%
DNMR NewDanimer Scientific, Inc.$11,755,000500,000
+100.0%
5.32%
GOOG  Alphabet Inc-Cl C$9,811,000
+19.2%
5,6000.0%4.44%
-8.1%
CLMT BuyCalumet Specialty Products Partners, LP$8,279,000
+60.7%
2,645,000
+30.9%
3.75%
+24.0%
MDWT BuyMidwest Holdings Inc.$7,705,000
+517.9%
143,621
+72.3%
3.49%
+376.4%
FSK NewFS KKR Capital Corp.$6,544,000395,175
+100.0%
2.96%
PFE SellPfizer Inc.$4,413,000
-8.8%
119,900
-9.1%
2.00%
-29.7%
LKQ SellLKQ Corporation$4,229,000
+1.7%
120,000
-20.0%
1.91%
-21.6%
KKR  KKR & Co. Inc.$4,049,000
+17.9%
100,0000.0%1.83%
-9.1%
GILD BuyGilead Sciences, Inc.$3,778,000
+443.6%
64,842
+489.5%
1.71%
+319.1%
KW  Kennedy-Wilson Holdings, Inc.$3,757,000
+23.2%
210,0000.0%1.70%
-5.0%
EIGR BuyEiger BioPharmaceuticals, Inc.$3,626,000
+61.8%
295,035
+7.1%
1.64%
+24.8%
ABBV SellAbbVie Inc.$3,511,000
+6.1%
32,769
-13.2%
1.59%
-18.1%
VXX NewiPath Series B S&P 500 VIX Short-Term Fut$3,358,000200,000
+100.0%
1.52%
EBC NewEastern Bankshares Inc$3,262,000200,000
+100.0%
1.48%
BMY BuyBristol-Myers Squibb Company$3,251,000
+16.2%
52,409
+12.9%
1.47%
-10.4%
HZNP BuyHorizon Therapeutics Public Ltd. Company$3,117,000
+6.9%
42,614
+13.5%
1.41%
-17.5%
XENE BuyXenon Pharmaceuticals Inc.$3,076,000
+57.0%
200,000
+13.0%
1.39%
+21.1%
KDMN BuyKadmon Holdings, Inc.$2,913,000
+21.4%
702,000
+14.7%
1.32%
-6.4%
TGTX  TG Therapeutics Inc.$2,641,000
+94.3%
50,7730.0%1.20%
+49.9%
CAPU NewCapitol Investment Corp. V$2,575,000250,000
+100.0%
1.16%
SellTrillium Therapeutics Inc.$2,570,000
+2.6%
174,699
-0.9%
1.16%
-20.8%
JPM SellJP Morgan Chase$2,538,000
+14.4%
19,970
-13.4%
1.15%
-11.8%
AUPH BuyAurinia Pharmaceuticals Inc.$2,455,000
+23.8%
177,540
+31.9%
1.11%
-4.5%
ZGNX  Zogenix, Inc.$2,253,000
+11.5%
112,7070.0%1.02%
-14.0%
MPLX  MPLX LP$2,165,000
+37.5%
100,0000.0%0.98%
+6.2%
HZAC NewHorizon Aquistion Corporation$2,105,000210,100
+100.0%
0.95%
RTP NewReinvent Technology Partners$2,037,000176,226
+100.0%
0.92%
IGT  International Gaming Technologies$1,821,000
+52.3%
107,5000.0%0.82%
+17.4%
CHRS BuyCoherus Biosciences, Inc.$1,767,000
-3.2%
101,655
+2.2%
0.80%
-25.3%
AB  AllianceBernstein Holding PL Unit Ltd.$1,706,000
+24.9%
50,5000.0%0.77%
-3.6%
ALXN SellAlexion Pharamaceuticals, Inc.$1,648,000
+20.0%
10,545
-12.1%
0.75%
-7.4%
BCRX SellBioCryst Pharmaceuticals, Inc.$1,635,000
+19.8%
219,461
-44.8%
0.74%
-7.6%
BDSI SellBioDelivery Sciences International, Inc.$1,555,000
-13.5%
370,230
-23.2%
0.70%
-33.3%
VAPO  Vapotherm, Inc.$1,316,000
-7.4%
49,0000.0%0.60%
-28.5%
QURE BuyuniQure N.V.$1,265,000
+10.8%
35,000
+12.9%
0.57%
-14.6%
VKTX  Viking Therapeutics, Inc.$1,228,000
-3.2%
218,1020.0%0.56%
-25.4%
VZ  Verizon Communications$1,076,000
-1.3%
18,3110.0%0.49%
-23.9%
JNJ SellJohnson & Johnson$956,000
-11.8%
6,080
-16.5%
0.43%
-31.9%
CNST NewConstellation Phamaceuticals, Inc.$950,00033,000
+100.0%
0.43%
MDLZ  Mondelez Int'l Inc.$930,000
+1.8%
15,9000.0%0.42%
-21.5%
VRCA BuyVerrica Pharmaceuticals, Inc.$881,000
+146.8%
76,585
+66.0%
0.40%
+90.9%
DD  Dupont De Nemours Inc.$861,000
+28.1%
12,1180.0%0.39%
-1.0%
RHP  Ryman Hospitality Ppty Inc.$840,000
+83.8%
12,4000.0%0.38%
+41.8%
CDTX BuyCidara Therapeutics, Inc.$831,000
-28.4%
415,308
+2.0%
0.38%
-44.8%
KMB  Kimberly Clark Corporation$809,000
-8.7%
6,0000.0%0.37%
-29.6%
KO  Coca Cola$735,000
+11.2%
13,4000.0%0.33%
-14.2%
DOW  Dow Inc.$673,000
+18.1%
12,1180.0%0.30%
-8.7%
NewStrongbridge Biopharma PLC$647,000266,194
+100.0%
0.29%
T  AT&T Inc.$634,000
+1.0%
22,0500.0%0.29%
-22.0%
AVDL NewAvadel Pharmaceuticals plc$581,00086,916
+100.0%
0.26%
IBM  International Business Machines$539,000
+3.5%
4,2840.0%0.24%
-20.3%
CNQ SellCanadian Natural Resources Inc.$536,000
+4.5%
22,285
-30.4%
0.24%
-19.3%
MIC  Macquarie Infrastructure Corporation$494,000
+39.5%
13,1500.0%0.22%
+7.7%
CTVA  Corveta Inc.$486,000
+34.6%
12,5450.0%0.22%
+3.8%
QUOT NewQuotient Technology Inc.$471,00050,000
+100.0%
0.21%
RDUS SellRadius Health Inc.$447,000
-18.0%
25,034
-47.9%
0.20%
-36.9%
WPC  WP Carey$423,000
+8.2%
6,0000.0%0.19%
-16.6%
EDIT NewEditas Medicine Inc.$421,0006,000
+100.0%
0.19%
FGEN SellFibroGen, Inc.$371,000
-54.3%
10,000
-49.3%
0.17%
-64.7%
LGVW NewLongview Aquisition Corp.$364,00018,380
+100.0%
0.16%
CAG  Conagra Brands$363,000
+1.7%
10,0000.0%0.16%
-21.5%
TARA BuyProtara Therapeutics, Inc.$348,000
+159.7%
14,369
+80.8%
0.16%
+98.7%
NewAlimera Sciences, Inc.$338,00080,194
+100.0%
0.15%
MSFT  Microsoft Corporation$311,000
+5.8%
1,4000.0%0.14%
-18.0%
NewMarinus Pharmaceutical, Inc.$305,00025,000
+100.0%
0.14%
GMED BuyGlobus Medical, Inc.$302,000
+109.7%
4,631
+59.7%
0.14%
+63.1%
AAPL SellApple Inc.$279,000
-42.6%
2,100
-50.0%
0.13%
-55.8%
ALXO BuyALX Oncology. Inc$276,000
+144.2%
3,200
+6.7%
0.12%
+89.4%
FSBW  FS Bancorp$196,000
+33.3%
3,5770.0%0.09%
+3.5%
IBB  iShares Nasdaq Biotechnology ETF$151,000
+11.9%
1,0000.0%0.07%
-13.9%
SSB  South Street Corporation$151,000
+49.5%
2,0820.0%0.07%
+15.3%
KHC  The Kraft Heinz Company$147,000
+15.7%
4,2340.0%0.07%
-10.7%
LEGH  Legacy Housing Corporation$136,000
+10.6%
9,0000.0%0.06%
-13.9%
MDT  Medtronics$123,000
+12.8%
1,0500.0%0.06%
-12.5%
VLY  Valley National Bancorp$121,000
+40.7%
12,4800.0%0.06%
+10.0%
TTE  Total SA$120,000
+22.4%
2,8600.0%0.05%
-5.3%
CUZ  Cousins Properties$112,000
+16.7%
3,3570.0%0.05%
-8.9%
HRGG  Heritage NOLA Bancorp Inc.$110,000
+13.4%
9,0000.0%0.05%
-12.3%
AXGT NewAxovant Gene Therapeutic, Ltd$111,00040,000
+100.0%
0.05%
 Merck & Co. Inc.$106,000
-0.9%
1,3000.0%0.05%
-23.8%
RLMD  Relmada Therapeutics, Inc.$96,000
-15.0%
3,0000.0%0.04%
-34.8%
FNB  FNB Corporation$85,000
+41.7%
8,9050.0%0.04%
+8.6%
CFFN  Capitol Federal S&L$73,000
+35.2%
5,8000.0%0.03%
+3.1%
CTIC NewCTI BioPharma Corp.$64,00020,000
+100.0%
0.03%
GE  General Electric$51,000
+75.9%
4,6800.0%0.02%
+35.3%
OXY  Occidental Pete Corp$51,000
+70.0%
2,9730.0%0.02%
+27.8%
LLY  Eli Lilly Inc.$51,000
+15.9%
3000.0%0.02%
-11.5%
BMYRT BuyBristol-Myers Squibb Company - CVR$45,000
+275.0%
64,720
+1144.6%
0.02%
+185.7%
ADMA SellADMA Biologics, Inc.$42,000
-73.1%
21,457
-67.1%
0.02%
-79.3%
CC  Chemours Co.$29,000
+20.8%
1,1600.0%0.01%
-7.1%
ACIU  AC Immune SA$27,000
+3.8%
5,3090.0%0.01%
-20.0%
EXP  Eagle Materials$23,000
+15.0%
2280.0%0.01%
-16.7%
LPTX NewLeap Therapeutics, Inc.$22,0009,700
+100.0%
0.01%
BNS  Bank Nova Scotia Halifax$22,000
+29.4%
4000.0%0.01%0.0%
PBCT  Peoples United Financial$19,000
+26.7%
1,5000.0%0.01%0.0%
DFPHU NewDFP Healthcare Acquistions Corp.$11,0001,000
+100.0%
0.01%
SVC  Service Ppty Trust$11,000
+37.5%
1,0000.0%0.01%0.0%
OXYWS  Occidental Pete Corp Wts exp 8/3/27$8,0003700.0%0.00%
STWD  Starwood Ppty$8,000
+33.3%
4000.0%0.00%0.0%
CLNY  Colony Cap Inc.$7,000
+75.0%
1,4660.0%0.00%
+50.0%
VTRS NewViatris Inc.$5,00080
+100.0%
0.00%
AMLP  Alerian MLP$3,000
+50.0%
1200.0%0.00%0.0%
SCU  Sculptor Capital Management$3,000
+50.0%
2000.0%0.00%0.0%
WAB  WABTEC$1,0000.0%230.0%0.00%
-100.0%
CHEK  Check Cap Ltd.$1,0000.0%2,2240.0%0.00%
-100.0%
RMR  RMR Group Inc.$1,000160.0%0.00%
CRDF ExitCardiff Oncology, Inc.$0-5,000
-100.0%
-0.04%
KRYS ExitKrystal Biotech, Inc.$0-7,079
-100.0%
-0.18%
CYTK ExitCytokinetics, Incorporated$0-15,837
-100.0%
-0.20%
CCXI ExitChemoCentryx, Inc.$0-6,587
-100.0%
-0.21%
ALIM ExitAlimera Sciences, Inc.$0-80,194
-100.0%
-0.23%
COLL ExitCollegium Pharmaceutical, Inc.$0-29,862
-100.0%
-0.36%
ALKS ExitAlkermes PLC$0-38,000
-100.0%
-0.37%
SBBP ExitStrongbridge Biopharma PLC$0-372,000
-100.0%
-0.46%
FSK ExitFS KKR Capital Corp.$0-395,175
-100.0%
-3.68%
SRCL ExitStericycle, Inc.$0-160,000
-100.0%
-5.92%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Ligand Pharmaceuticals Incorporated34Q3 202152.6%
Pfizer Inc.34Q3 202117.4%
Capitol Federal S&L34Q3 20215.7%
JP Morgan Chase& Co.34Q3 20211.3%
Apple Inc.34Q3 20212.1%
Microsoft Corporation34Q3 20212.3%
AllianceBernstein Holdings PL Unit Ltd.34Q3 20210.9%
Johnson & Johnson34Q3 20210.6%
Mondelez Int'lt Inc.34Q3 20210.5%
Ryman Hospitality PPTYS Inc.34Q3 20210.4%

View KNOTT DAVID M's complete holdings history.

Latest significant ownerships (13-D/G)
KNOTT DAVID M Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
LIGAND PHARMACEUTICALS INCFebruary 13, 2018865,5004.1%
Rand Logistics, Inc.November 15, 20171,432,6607.2%
Essex Rental Corp.August 16, 20131,124,4724.5%
Westway Group, Inc.February 01, 2013? ?
FutureFuel Corp.February 01, 20121,838,0004.5%
COLUMBIA LABORATORIES INCJanuary 31, 2012? ?
Essex Rental Corp.February 16, 20112,805,66613.0%
Pet DRx CORPSold outFebruary 09, 201100.0%
China Ceramics Co., LtdOctober 14, 20101,350,00010.3%
NABI BIOPHARMACEUTICALSJune 22, 20102,344,5974.8%

View KNOTT DAVID M's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2021-11-12
13F-HR2021-08-13
13F-HR2021-05-13
13F-HR2021-02-12
13F-HR2020-11-13
13F-HR2020-08-12
13F-HR2020-05-13
13F-HR2020-02-14
13F-HR2019-11-12
13F-HR2019-08-12

View KNOTT DAVID M's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (220973000.0 != 220972000.0)

Export KNOTT DAVID M's holdings